Literature DB >> 22531750

Involvement of spinal monocyte chemoattractant protein-1 (MCP-1) in cancer-induced bone pain in rats.

Ji-Hua Hu1, Xiao-Yan Zheng, Jian-Ping Yang, Li-Na Wang, Fu-Hai Ji.   

Abstract

In this study, we examined the involvement of chemokine monocyte chemoattractant protein-1 (MCP-1) in the spinal cord of a rat model of cancer-induced bone pain (CIBP). In this model, CIBP was established by an intramedullary injection of Walker 256 cells into the tibia of rats. We observed a significant increase in expression levels of MCP-1 and its receptor CCR2 in the spinal cord of CIBP rats. Furthermore, the intrathecal administration of an anti-MCP-1 neutralizing antibody attenuated the mechanical allodynia established in CIBP rats. Likewise, an intrathecal injection of exogenous recombinant MCP-1 induced a striking mechanical allodynia in naïve rats. These results suggest that increases in spinal MCP-1 and CCR2 expression are involved in the development of mechanical allodynia associated with bone cancer rats.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531750     DOI: 10.1016/j.neulet.2012.04.026

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  Involvement of spinal chemokine CCL2 in the hyperalgesia evoked by bone cancer in mice: a role for astroglia and microglia.

Authors:  Marta Pevida; Sara González-Rodríguez; Ana Lastra; Olivia García-Suárez; Agustín Hidalgo; Luis Menéndez; Ana Baamonde
Journal:  Cell Mol Neurobiol       Date:  2014-01       Impact factor: 5.046

2.  The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.

Authors:  Katarzyna Pawlik; Anna Piotrowska; Klaudia Kwiatkowski; Katarzyna Ciapała; Katarzyna Popiolek-Barczyk; Wioletta Makuch; Joanna Mika
Journal:  Immunology       Date:  2020-02-05       Impact factor: 7.397

Review 3.  Cancer-induced bone pain: Mechanisms and models.

Authors:  A N Lozano-Ondoua; A M Symons-Liguori; T W Vanderah
Journal:  Neurosci Lett       Date:  2013-09-25       Impact factor: 3.046

4.  Decreased miR-325-5p Contributes to Visceral Hypersensitivity Through Post-transcriptional Upregulation of CCL2 in Rat Dorsal Root Ganglia.

Authors:  Rui Wu; Ping-An Zhang; Xuelian Liu; Yuan Zhou; Meijie Xu; Xinghong Jiang; Jun Yan; Guang-Yin Xu
Journal:  Neurosci Bull       Date:  2019-04-12       Impact factor: 5.203

5.  Chemokine ligand 2 in the trigeminal ganglion regulates pain induced by experimental tooth movement.

Authors:  Zhi Yang; Wei Luo; Jing Wang; Yu Tan; Runqing Fu; Bing Fang
Journal:  Angle Orthod       Date:  2014-01-13       Impact factor: 2.079

6.  Upregulation of (C-X-C motif) Ligand 13 (CXCL13) Attenuates Morphine Analgesia in Rats with Cancer-Induced Bone Pain.

Authors:  Shi-Feng Wang; Cheng-Gong Dong; Xue Yang; Jian-Jun Yin
Journal:  Med Sci Monit       Date:  2016-11-28

7.  The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer.

Authors:  Ørnulf Paulsen; Barry Laird; Nina Aass; Tor Lea; Peter Fayers; Stein Kaasa; Pål Klepstad
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

Review 8.  Use of Animal Models in Understanding Cancer-induced Bone Pain.

Authors:  Lauren M Slosky; Tally M Largent-Milnes; Todd W Vanderah
Journal:  Cancer Growth Metastasis       Date:  2015-08-23

9.  CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord.

Authors:  Wen Shen; Xue-Ming Hu; Yan-Nan Liu; Yuan Han; Li-Ping Chen; Chen-Chen Wang; Chao Song
Journal:  J Neuroinflammation       Date:  2014-04-16       Impact factor: 8.322

10.  NFκB-mediated CXCL1 production in spinal cord astrocytes contributes to the maintenance of bone cancer pain in mice.

Authors:  Jie Xu; Ming-Di Zhu; Xin Zhang; Hao Tian; Jin-Hua Zhang; Xiao-Bo Wu; Yong-Jing Gao
Journal:  J Neuroinflammation       Date:  2014-03-01       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.